Tandem Health Secures $100 Million in Series B Funding Led by EQT

Tandem Health Raises $100 Million in Series B Funding

Tandem Health, a Stockholm-based company specializing in capturing consultations and preparing structured clinical notes for review, has successfully raised $100 million in a Series B funding round. The investment was led by EQT's Scaleup Europe Fund, with participation from other investors including Kinnevik, Northzone, Amino Collective, and Visionaries Club.

Leadership at Tandem Health

Lukas Saari, CEO and Co-Founder of Tandem Health, along with Oliver Åstrand, CTO and Co-Founder, have been instrumental in driving the company's growth. Their platform is designed to ensure safe and compliant use across clinical care, streamlining the documentation process for healthcare providers.

Strategic Use of Funds

The newly acquired funds are set to be directed towards enhancing their technology and expanding their market reach. This move is expected to bolster Tandem Health's capabilities in clinical documentation, allowing them to serve a broader client base and improve healthcare outcomes.

Investor Confidence

The participation of notable investors such as Kinnevik, Northzone, Amino Collective, and Visionaries Club, alongside EQT's Scaleup Europe Fund, indicates strong confidence in Tandem Health's innovative approach to healthcare technology.

With this significant financial backing, Tandem Health is well-positioned to continue its mission of transforming clinical documentation processes, ensuring that healthcare providers can focus more on patient care and less on administrative tasks.